Cargando…

Overexpression of CXCR4 is significantly associated with cisplatin-based chemotherapy resistance and can be a prognostic factor in epithelial ovarian cancer

The chemokine receptor 4 (CXCR4) plays an important role in the growth, angiogenesis and metastasis of various cancers, including epithelial ovarian cancer (EOC). However, the correlation between CXCR4 and the clinical response of EOC patients to chemotherapy remains unknown. 124 EOC patients were r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jia, Jiang, Kuo, Qiu, Xiuchun, Li, Meng, Hao, Qiang, Wei, Li, Zhang, Wei, Chen, BiLiang, Xin, Xiaoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society for Biochemistry and Molecular Biology 2014
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163846/ https://www.ncbi.nlm.nih.gov/pubmed/24209634 http://dx.doi.org/10.5483/BMBRep.2014.47.1.069

Ejemplares similares

Intraoperative intraperitoneal chemotherapy with cisplatin in epithelial ovarian cancer
por: Kim, Myung Joo, et al.
Publicado: (2012)

Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
por: Zhang, P, et al.
Publicado: (2014)

Dense hyperthermic intraperitoneal chemotherapy with cisplatin in patients with stage III serous epithelial ovarian cancer: a retrospective study
por: He, Xiaoli, et al.
Publicado: (2021)

Down-regulation of OGT promotes cisplatin resistance by inducing autophagy in ovarian cancer
por: Zhou, Fuxing, et al.
Publicado: (2018)

The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
por: Wu, Wei, et al.
Publicado: (2014)

Effect of bevacizumab combined with chemotherapy on SDF-1 and CXCR4 in epithelial ovarian cancer and its prognosis
por: Ma, Chunyan
Publicado: (2022)

The relationship between cisplatin resistance and histone deacetylase isoform overexpression in epithelial ovarian cancer cell lines
por: Kim, Min-Gyun, et al.
Publicado: (2012)

Overexpression of SMARCA2 or CAMK2D is associated with cisplatin resistance in human epithelial ovarian cancer
por: Xu, Xiaoli, et al.
Publicado: (2018)

Expression of SDF-1 and CXCR4 transcript variants and CXCR7 in epithelial ovarian cancer
por: JASZCZYNSKA-NOWINKA, KAROLINA, et al.
Publicado: (2014)

Retraction: The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
por: Wu, Wei, et al.
Publicado: (2020)

Overexpression of DUSP6 enhances chemotherapy-resistance of ovarian epithelial cancer by regulating the ERK signaling pathway
por: Gao, Yan, et al.
Publicado: (2020)

Dysbindin facilitates invasion and metastasis by promoting phosphorylation of ERK in epithelial ovarian cancer
por: Lv, Xiaohui, et al.
Publicado: (2020)

Prognostic Significance of Lymphovascular Space Invasion in Epithelial Ovarian Cancer
por: Chen, Ming, et al.
Publicado: (2015)

Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma
por: Guo, Li, et al.
Publicado: (2011)

Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients
por: Wang, Wu-yun, et al.
Publicado: (2021)

The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer
por: Zhou, Yingying, et al.
Publicado: (2015)

Targeting CXCR2 inhibits the progression of lung cancer and promotes therapeutic effect of cisplatin
por: Cheng, Yuan, et al.
Publicado: (2021)

Overexpression of JARID1B is associated with poor prognosis and chemotherapy resistance in epithelial ovarian cancer
por: Wang, Lishuang, et al.
Publicado: (2015)

Reduced O-GlcNAcylation of SNAP-23 promotes cisplatin resistance by inducing exosome secretion in ovarian cancer
por: Qian, Luomeng, et al.
Publicado: (2021)

Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment
por: Henriques, Taciane Barbosa, et al.
Publicado: (2021)

NuMA Overexpression in Epithelial Ovarian Cancer
por: Brüning-Richardson, Anke, et al.
Publicado: (2012)

Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation
por: Dong, Lijuan, et al.
Publicado: (2016)

Hyperthermic intrathoracic chemotherapy with cisplatin for ovarian cancer with pleural metastasis
por: Jun, Su Youn, et al.
Publicado: (2017)

Dickkopf-4 is frequently overexpressed in epithelial ovarian carcinoma and promotes tumor invasion
por: Wang, Shizhuo, et al.
Publicado: (2017)

Deregulation of Exo70 Facilitates Innate and Acquired Cisplatin Resistance in Epithelial Ovarian Cancer by Promoting Cisplatin Efflux
por: Zhao, Yujie, et al.
Publicado: (2021)

Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer
por: Guo, Jianfeng, et al.
Publicado: (2021)

Isoalantolactone Suppresses Glycolysis and Resensitizes Cisplatin-Based Chemotherapy in Cisplatin-Resistant Ovarian Cancer Cells
por: Chun, Jaemoo
Publicado: (2023)

Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
por: Liang, Sixian, et al.
Publicado: (2014)

Pharmacokinetics of concomitant cisplatin and paclitaxel administered by hyperthermic intraperitoneal chemotherapy to patients with peritoneal carcinomatosis from epithelial ovarian cancer
por: Ansaloni, L, et al.
Publicado: (2015)

Prognostic significance of CXCR4 expression in acute myeloid leukemia
por: Du, Wen, et al.
Publicado: (2019)

Chemotherapy-Induced Neutropenia as a Prognostic Factor in Patients With Advanced Epithelial Ovarian Carcinoma
por: Xu, Yaping, et al.
Publicado: (2023)

The Role of SDF-1/CXCR4/CXCR7 in Neuronal Regeneration after Cerebral Ischemia
por: Cheng, Xi, et al.
Publicado: (2017)

Combination of Cisplatin, Ifosfamide, and Adriamycin as Neoadjuvant Chemotherapy for Extremity Soft Tissue Sarcoma: A Report of Twenty-Eight Patients
por: Wang, Bing, et al.
Publicado: (2016)

Nanoparticles functionalized with stem cell secretome and CXCR4-overexpressing endothelial membrane for targeted osteoporosis therapy
por: Zhang, Chi, et al.
Publicado: (2022)

Overexpression of TMEM158 contributes to ovarian carcinogenesis
por: Cheng, Zhongping, et al.
Publicado: (2015)

Overexpression of the Survivin gene in SGC7901 cell resistance to cisplatin
por: DONG, HANZHANG, et al.
Publicado: (2014)

Suicide Gene Reveals the Myocardial Neovascularization Role of Mesenchymal Stem Cells Overexpressing CXCR4 (MSC(CXCR4))
por: Liang, Jialiang, et al.
Publicado: (2012)

SNHG22 overexpression indicates poor prognosis and induces chemotherapy resistance via the miR-2467/Gal-1 signaling pathway in epithelial ovarian carcinoma
por: Zhang, Peng-Fei, et al.
Publicado: (2019)

Hyperthermic intraperitoneal chemotherapy for recurrent epithelial ovarian cancer
por: Chen, Wei-Chun, et al.
Publicado: (2022)

Correction: Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
por: Liang, Sixian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a3oj81rus3i17ulqhopkj2p7j9